Pivot Park

Pivot Park

Europe’s foremost biopharmaceutical campus. Learn more

Recent News about Pivot Park

Edit
More about Pivot Park
Edit

Pivot Park was founded in 2012 to provide the optimal European location for innovative pharmaceutical companies. Today, this advanced science campus helps early-phase entrepreneurs, fast-growth scale-ups and mature global leaders take their next steps in their ambition to improve global health care. As home to 600 people working at over 60 companies, we make sure they have what they need to succeed. The park combines lab and office spaces with high-quality R&D facilities, two GMP-certified pilot plants, an Ultra-High-Throughput Screening Centre, on-site analytical support and a well-equipped Open Access Laboratory. This is backed up by having various companies at Pivot Park that provide a wide range of essential pharma support services. These include routes to specialist finance, shared gateways to knowledge and access to outstanding scientific and entrepreneurial expertise. As a result, Pivot Park is now the hotspot for pharmaceutical innovation in Europe. And with ambitious plans for future growth, we are well on our way to creating the dynamic and uniquely pharma-based knowledge community of our dreams. Pivot Park is located in Oss, the spiritual home of the Netherlands’ pharmaceutical industry. Besides offering a wonderful work-life balance, being located in Oss places Pivot Park at the heart of a vibrant ecosystem of universities, educational institutes, research institutes and centres of excellence that work in similar and related fields.

Portfolio analysisEdit

Supported companies by Pivot Park

Edit
SynAffix
ACQUISITION by Lonza Jun 2023
Acerta Pharma
ACQUISITION by AstraZeneca Feb 2016
Certara
BUYOUT by EQT Group Jul 2017
Ardena
ACQUISITION by GHO Capital Jan 2020
View 47 more